Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 243.63K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -21.29M | Forward P/E | -0.04 | EPS next Y | - | 50D Avg Chg | -76.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -93.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | 75.00% | 52W High Chg | -99.00% |
| Recommedations | 3.00 | Quick Ratio | 3.44 | Shares Outstanding | 4.87M | 52W Low Chg | 400.00% |
| Insider Own | 1.07% | ROA | -56.29% | Shares Float | 4.78M | Beta | -0.30 |
| Inst Own | - | ROE | -114.14% | Shares Shorted/Prior | 417.28K/148.51K | Price | 0.05 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 48,303 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 1,303 | Change | 0.00% |
About CALITHERA BIOSCIENCES INC
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.